国药科技股份有限公司（股票代码：08156）于2026年11月5日公布2026年10月止的股份变动月报表。公告显示，报告期内公司法定股本保持在200,000,000港元，包含12,800,000,000股普通股（面值每股0.0125港元）及3,200,000,000股可换股优先股（面值每股0.0125港元），与上月无异动。
截至2026年10月31日，普通股已发行股份总数为633,693,055股，可换股优先股已发行股份总数为1,480,151,050股。公司当月没有新增股份发行、购回或注销，股本结构维持不变。公司此前授出的“2021购股权计划”显示，现有4,960,000份购股权，行使价为每股1港元。声明亦显示，公司遵守了香港联交所《上市规则》及相关法律法规，所有发行及披露均经董事会正式授权并符合合规要求。
本次公告由公司执行董事郭淑仪签署，确认截至月末公司股本维持稳定。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.